{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:40:08Z","timestamp":1749325208350,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Each year, nearly one-fifth of adults in the United States are prescribed at least one psychotropic medication. An increased trend in psychiatric polypharmacy has heightened awareness of drug-drug interactions and the tracking of adverse drug reactions. This article describes a patient who developed concomitant neuroleptic malignant syndrome (NMS) and nephrogenic diabetes insipidus during cross-titration of his antipsychotics while on lithium. The patient's mild form of NMS in turn caused hypovolemia and acute kidney injury. This case study highlights the dangers of polypharmacy and how it can obscure the presentation of even classic adverse reactions.<\/jats:p>","DOI":"10.1097\/01.jaa.0000840488.74228.46","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T18:27:54Z","timestamp":1658860074000},"page":"31-33","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Concomitant neuroleptic malignant syndrome and diabetes insipidus"],"prefix":"10.1097","volume":"35","author":[{"given":"Carlee","family":"Zaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Ugell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang","family":"Vo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"2","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamainternmed.2016.7507","article-title":"Adult utilization of psychiatric drugs and differences by sex, age, and race","volume":"177","author":"Moore","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12877-017-0428-1","article-title":"Variation in use of antipsychotic medications in nursing homes in the United States: a systematic review","volume":"17","author":"Cioltan","year":"2017","journal-title":"BMC Geriatr"},{"issue":"1","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0035-1553246","article-title":"Das maligne neuroleptische syndrom (MNS)\u2014eine systematische \u00fcbersicht [the neuroleptic malignant syndrome]","volume":"83","author":"Nagel","year":"2015","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"6","key":"R5-20250607","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"5","key":"R6-20250607","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/acps.12694","article-title":"A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency","volume":"135","author":"Gurrera","year":"2017","journal-title":"Acta Psychiatr Scand"},{"article-title":"Neuroleptic malignant syndrome","year":"2020","author":"Simon","key":"R7-20250607"},{"issue":"11","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1060028016657553","article-title":"Neuroleptic malignant syndrome: focus on treatment and rechallenge","volume":"50","author":"Pileggi","year":"2016","journal-title":"Ann Pharmacotherapy"},{"issue":"11","key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"P\u00e9tursson","year":"1994","journal-title":"Addiction"},{"article-title":"Anticholinergic toxicity","year":"2020","author":"Broderick","key":"R10-20250607"},{"issue":"5","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Gr\u00fcnfeld","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"3 Pt 2","key":"R12-20250607","first-page":"F505","article-title":"Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats","volume":"261","author":"Yamaki","year":"1991","journal-title":"Am J Physiol"},{"issue":"10","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"R14-20250607","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2215\/CJN.01640408","article-title":"Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride","volume":"3","author":"Bedford","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000840488.74228.46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:00:59Z","timestamp":1749322859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000840488.74228.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000840488.74228.46","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}